Park S, Park M, Kim E, Kim J, Cho J, Huh Y
iScience. 2025; 28(2):111631.
PMID: 39911347
PMC: 11795144.
DOI: 10.1016/j.isci.2024.111631.
Udo M, Zaccarelli-Magalhaes J, Clemons G, Citadin C, Langman J, Smith D
Geroscience. 2025; .
PMID: 39843732
DOI: 10.1007/s11357-025-01526-8.
Power S, Venkatesan S, Qu S, McLaurin J, Lambe E
Transl Neurodegener. 2024; 13(1):58.
PMID: 39623428
PMC: 11613856.
DOI: 10.1186/s40035-024-00452-7.
Jager R, Abou Sawan S, Orru M, Tinsley G, Purpura M, Wells S
Exp Brain Res. 2024; 243(1):8.
PMID: 39617850
PMC: 11609120.
DOI: 10.1007/s00221-024-06954-0.
De Plano L, Saitta A, Oddo S, Caccamo A
Biomolecules. 2024; 14(11).
PMID: 39595581
PMC: 11592094.
DOI: 10.3390/biom14111405.
Distinct Disruptions in CA1 and CA3 Place Cell Function in Alzheimer's Disease Mice.
Park S, Park M, Kim E, Kim J, Huh Y, Cho J
bioRxiv. 2024; .
PMID: 39386433
PMC: 11463587.
DOI: 10.1101/2024.09.23.614631.
An Expanded Narrative Review of Neurotransmitters on Alzheimer's Disease: The Role of Therapeutic Interventions on Neurotransmission.
Akyuz E, Arulsamy A, Aslan F, Sarisozen B, Guney B, Hekimoglu A
Mol Neurobiol. 2024; 62(2):1631-1674.
PMID: 39012443
PMC: 11772559.
DOI: 10.1007/s12035-024-04333-y.
Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP/PS1 mice.
Gomez-Murcia V, Launay A, Carvalho K, Burgard A, Meriaux C, Caillierez R
Brain. 2024; 147(8):2691-2705.
PMID: 38964748
PMC: 11292904.
DOI: 10.1093/brain/awae113.
Drug Development for Alzheimer's and Parkinson's Disease: Where Do We Go Now?.
Sequeira L, Benfeito S, Fernandes C, Lima I, Peixoto J, Alves C
Pharmaceutics. 2024; 16(6).
PMID: 38931832
PMC: 11206728.
DOI: 10.3390/pharmaceutics16060708.
Effect of Xanthohumol, a Bioactive Natural Compound from Hops, on Adenosine Pathway in Rat C6 Glioma and Human SH-SY5Y Neuroblastoma Cell Lines.
Tejero A, Leon-Navarro D, Martin M
Nutrients. 2024; 16(11).
PMID: 38892725
PMC: 11174739.
DOI: 10.3390/nu16111792.
Adenosine A Receptor Blockade Provides More Effective Benefits at the Onset Rather than after Overt Neurodegeneration in a Rat Model of Parkinson's Disease.
Nunes A, Carmo M, Behrenswerth A, Canas P, Agostinho P, Cunha R
Int J Mol Sci. 2024; 25(9).
PMID: 38732120
PMC: 11084368.
DOI: 10.3390/ijms25094903.
Effects of Cyfluthrin Exposure on Neurobehaviour, Hippocampal Tissue and Synaptic Plasticity in Wistar Rats.
Xie Y, Zhao J, Li X, Sun J, Yang H
Toxics. 2023; 11(12).
PMID: 38133400
PMC: 10748044.
DOI: 10.3390/toxics11120999.
Blockade of adenosine A receptors reverses early spatial memory defects in the APP/PS1 mouse model of Alzheimer's disease by promoting synaptic plasticity of adult-born granule cells.
Ji Q, Yang Y, Xiong Y, Zhang Y, Jiang J, Zhou L
Alzheimers Res Ther. 2023; 15(1):187.
PMID: 37899431
PMC: 10614339.
DOI: 10.1186/s13195-023-01337-z.
Modification of astrocytic Cx43 hemichannel activity in animal models of AD: modulation by adenosine A receptors.
Madeira D, Domingues J, Lopes C, Canas P, Cunha R, Agostinho P
Cell Mol Life Sci. 2023; 80(11):340.
PMID: 37898985
PMC: 10613596.
DOI: 10.1007/s00018-023-04983-6.
Synaptic Compensatory Plasticity in Alzheimer's Disease.
Bhembre N, Bonthron C, Opazo P
J Neurosci. 2023; 43(41):6833-6840.
PMID: 37821232
PMC: 10573755.
DOI: 10.1523/JNEUROSCI.0379-23.2023.
Pharmacology of Adenosine Receptors: Recent Advancements.
Vincenzi F, Pasquini S, Contri C, Cappello M, Nigro M, Travagli A
Biomolecules. 2023; 13(9).
PMID: 37759787
PMC: 10527030.
DOI: 10.3390/biom13091387.
Chemobrain: An accelerated aging process linking adenosine A receptor signaling in cancer survivors.
Oliveros A, Poleschuk M, Cole P, Boison D, Jang M
Int Rev Neurobiol. 2023; 170:267-305.
PMID: 37741694
PMC: 10947554.
DOI: 10.1016/bs.irn.2023.08.003.
Adenosine A Receptor Up-Regulation Pre-Dates Deficits of Synaptic Plasticity and of Memory in Mice Exposed to Aβ to Model Early Alzheimer's Disease.
Lopes C, Silva A, Silva H, Canas P, Agostinho P, Cunha R
Biomolecules. 2023; 13(8).
PMID: 37627238
PMC: 10452250.
DOI: 10.3390/biom13081173.
The interwoven fibril-like structure of amyloid-beta plaques in mouse brain tissue visualized using super-resolution STED microscopy.
Johansson B, Oasa S, Muntsant Soria A, Tiiman A, Soderberg L, Amandius E
Cell Biosci. 2023; 13(1):142.
PMID: 37542303
PMC: 10403925.
DOI: 10.1186/s13578-023-01086-4.
Long-term potentiation-based screening identifies neuronal PYGM as a synaptic plasticity regulator participating in Alzheimer's disease.
Wang T, Zhou Y, Wang Y, Zhang L, Zhu X, Wang X
Zool Res. 2023; 44(5):867-881.
PMID: 37537141
PMC: 10559100.
DOI: 10.24272/j.issn.2095-8137.2023.123.